Mountain Capital Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Mountain Capital Investment Advisors's GILD Position: Q1 2024 in Review
Mountain Capital Investment Advisors sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 13,824 shares — an estimated $1.16M sold.
Mountain Capital Investment Advisors first reported a position in GILD in Q2 2017 and held it in 16 quarters. The position peaked at $3.02M in Q1 2023. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- Mountain Capital Investment Advisors reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
- Mountain Capital Investment Advisors sold 13,824 Gilead Sciences shares in Q1 2024, an estimated $1.16M.
- Mountain Capital Investment Advisors first reported a position in Gilead Sciences in Q2 2017 and held it in 16 quarters.
- Mountain Capital Investment Advisors's Gilead Sciences position peaked at $3.02M in Q1 2023.
- 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on Mountain Capital Investment Advisors's 13F filing for Q1 2024, filed 11 Apr 2024.